Evrofarma SA Capital Reinvestment Ratio
Evrofarma SA capital reinvestment ratio. Evrofarma SA (EVROF) has a Capital Reinvestment Ratio of 0.41x as of December 2022, meaning it reinvests 0% of its operating cash flow (€1.52 Million) in capital expenditures (€615.00K). Check Evrofarma SA (EVROF) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Evrofarma SA (2014–2022)
Capital reinvestment ratio of Evrofarma SA from 2014 to 2022. This chart tracks Evrofarma SA's Capital Reinvestment Ratio across 8 annual periods. Also explore EVROF net asset momentum to track the company's year-over-year net asset growth rate.
Evrofarma SA Capital Reinvestment Ratio by Year (2014–2022)
Evrofarma SA capital reinvestment ratio by year from 2014 to 2022. For the full cash flow conversion analysis, see Evrofarma SA operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.84x | €2.44 Million | €2.05 Million | ▲ +35.8% |
| 2020 | 0.62x | €1.46 Million | €904.00K | ▲ +26.0% |
| 2019 | 0.49x | €1.78 Million | €875.00K | ▲ +37.2% |
| 2018 | 0.36x | €2.29 Million | €822.00K | ▲ +37.5% |
| 2017 | 0.26x | €3.11 Million | €810.00K | ▲ +9.3% |
| 2016 | 0.24x | €1.08 Million | €258.00K | ▼ -35.2% |
| 2015 | 0.37x | €1.39 Million | €512.00K | ▼ -47.4% |
| 2014 | 0.70x | €866.00K | €607.00K | — |